Recombinant Human MTFMT Protein，His

MTFMT (Mitochondrial Methionyl-tRNA Formyltransferase) is a crucial enzyme involved in mitochondrial protein synthesis, specifically responsible for the modification of mitochondrial tRNA. This enzyme catalyzes the formylation of methionyl-tRNA, essential for the initiation of protein synthesis in the mitochondria of eukaryotic cells. The proper functioning of MTFMT is vital for maintaining mitochondrial health and overall cellular function, as it influences the translation of mitochondrial-encoded genes, which are pivotal for oxidative phosphorylation and ATP production. Deficiencies or mutations in MTFMT can lead to a range of mitochondrial disorders, characterized by impaired energy metabolism and associated with various clinical manifestations, including neurodegenerative diseases, muscular dystrophies, and cardiomyopathies. Given the increasing recognition of the role of mitochondrial dysfunction in numerous pathologies, research into MTFMT has gained significant attention. Studies have focused on elucidating the enzyme's structure, mechanism, and regulatory pathways, alongside exploring potential therapeutic strategies to modulate its activity. Understanding MTFMT functions not only provides insights into mitochondrial biology but also paves the way for developing interventions aimed at ameliorating mitochondrial diseases and enhancing mitochondrial health. This area of research holds promise for advancing therapies that target the underlying causes of mitochondrial dysfunction and improving the quality of life for affected individuals.